ACT Awards

SSO is pleased to offer the following awards to each of the recipients below:

2025 Gabriella Graham Award Winner
H. Richard Alexander, Jr., MD, FACS
Chief Surgical Officer, Rutgers Cancer Institute of New Jersey
System Director of Surgical Oncology at RWJBarnabas Health

Learn more about Gabriella Graham here.

ACPMP Travel Awards

Through the generosity of ACPMP (Appendix Cancer/Pseudomyxoma Peritonei Research Foundation), SSO is offering travel awards to the following abstract presenters. These abstracts received the highest scoring in the content/research areas of appendix cancer, pseudomyxoma peritonei, peritoneal surface malignancies/peritoneal carcinomatosis, and/or HIPEC.

Award winner announcements will take place during the ACT 2025 Meet the Professors Reception. Award recipients can pick up their award certificate at the ACPMP booth.

Development of Peritoneal Complications in Patients with Peritoneal Metastases Who are Not Candidates for Cytoreductive Surgery

Beatrice J. Sun, MD

Next generation sequencing identifies key targetable mutations in the treatment of appendiceal neoplasms

Rui Zheng-Pywell, MD

Tailored Surveillance for Mucinous Appendix Cancer after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Vladislav Kovalik, MD, MSPH

Tissue-based biomarkers of response to immune checkpoint blockade (ICB) in metastatic appendiceal adenocarcinoma (AA): validating spatial transcriptomics and proteomics of trial participants’ surgical specimens

Eleanor A. Fallon, MD

Clinical outcomes of high-grade appendiceal mucinous neoplasms

Ashlee N. Seldomridge, MD

P53 and/or SMAD4 mutations are associated with poorest survival in high-grade appendiceal peritoneal metastasis and may be a potential preoperative marker for CRS/HIPEC selection

Chunmeng Zhang

Ac-225 delivered by self-assembling dis-assembling (SADA) bispecific antibodies ablates colorectal and appendiceal peritoneal xenografts with minimal toxicity

Nicole Aguirre, MD

Histology of Recurrent Mucinous Appendiceal Cancer after CRS-HIPEC for Low Grade Peritoneal Metastases

Sohini Khan, MD

Young Investigator Award-Appendix Cancer Pseudomyxoma Peritonei (PMP)

Supported by a grant from ACPMP

The Society of Surgical Oncology Young Investigator Award promotes and recognizes clinical and translational research that advances innovative ideas and concepts designed to improve health outcomes through advances in the delivery of cancer-related care.

Through the generous support of the Appendix Cancer Pseudomyxoma Peritonei Research Foundation (ACPMP), SSO was able to offer a topic specific grant this year for a proposal related to appendiceal mucinous neoplasms, appendiceal adencarcinomas (including signet ring cell adenocarcinoma and goblet cell adenocarcinoma) and/or PMP of appendiceal origin; with a special interest in proposals that embrace moving this rare malignant tumor type forward to curative science.

Award winner announcements will take place during the ACT 2025 Meet the Professors Reception.

Kimberly Kopecky, MD, MSCI
University of Alabama at Birmingham

Lisa Kurtz Luciano Appendix Cancer and Pseudomyxoma Peritonei Clinical Investigator Award

Supported by a grant from ACPMP

The Society of Surgical Oncology Clinical Investigator Award promotes patient-focused research conducted by surgical oncologists in clinical and translational science.

Through the generous support of the Appendix Cancer Pseudomyxoma Peritonei Research Foundation (ACPMP), SSO was able to offer a topic specific grant this year for a proposal related appendiceal mucinous neoplasms, appendiceal adencarcinomas (including signet ring cell adenocarcinoma and goblet cell adenocarcinoma) and/or PMP of appendiceal origin; with a special interest in proposals that embrace moving this rare malignant tumor type forward to a curative science.

Award winner announcements will take place during the ACT 2025 Meet the Professors Reception.

Oliver Eng, MD
University of California, Irvine

For more information on ACPMP, please visit the ACT 2025 Supporters Website.